Health Care · Ophthalmic Goods · Nasdaq · CIK 718937 · FYE Jan 2 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $24.22Day +1.47%Mkt cap $1.2B1Y +33.8%Off 52W high −32.5%Vol (1Y) 70.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,294 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.3% of sh out |
| Days to cover7.7d |
| 13F net flow (QoQ)+2.12% |
| Top-10 13F concentration71.1% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$290.4M |
| Earnings (TTM)-$21.0M |
| ROE−21.7% |
| Net margin−33.6% |
| ROIC−44.8% |
| Sales growth 3Y0.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+4.9% |
| 1Y+33.8% |
| 3Y−55.8% |
| 5Y−81.1% |
| 10Y+250.0% |
| Since incept. (ann.)+9.6% |
Total return through 2026-07-30 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)70.9% |
| Ann. volatility (3Y)63.2% |
| Sharpe (1Y)0.69 |
| Sharpe (3Y)−0.13 |
| Max drawdown (1Y)−43.6% |
| Max drawdown (3Y)−72.4% |
| Beta (3Y vs SPY)1.09 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 16.1M | $302M | 32.57% | +7.4% |
| BlackRock, Inc. | 6.7M | $125M | 13.46% | −9.4% |
| Yunqi Capital Ltd | 3.3M | $61M | 6.58% | +29.9% |
| Madison Avenue Partners, LP | 2.4M | $46M | 4.93% | new |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.1M | $40M | 4.29% | new |
| STATE STREET CORP | 1.8M | $34M | 3.70% | −5.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $32M | 3.41% | new |
| Anatole Investment Management Ltd | 1.6M | $30M | 3.23% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 108.9% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 6,731,885 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-04-03 | 2026-05-13 | $0.10 | — | $93.5M | +119.6% |
| 2026-01-02 | 2026-03-03 | — | — | $57.8M | +18.1% |
| 2025-09-26 | 2025-11-05 | $0.18 | −10.0% | $94.7M | +6.9% |
| 2025-06-27 | 2025-08-06 | −$0.34 | −326.7% | $44.3M | −55.2% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
